OF HIV INFECTION

Guidance on Pre-exposure oral prophylaxis (PrEP) for serodiscordant couples, men who have sex with men and transgender women at high risk of HIV in..

Effective PrEP use is different from adherence to HIV treatment in that PrEP can be started and stopped as a person moves through “seasons of risk”, whereas treatment is

men CAPRISA 004 (topical) South Africa — Women iPrEx Brazil, Ecuador, Peru, South Africa, Thailand, US — MSM Partners PrEP Kenya, Uganda — SDC FEM-PrEP Kenya, South Africa, Tanzania

Following the WHO recommendation in September 2015 that “oral pre-exposure prophylaxis (PrEP) should be offered as an additional prevention choice for people at substantial risk of

Increasing evidence to support earlier ART initiation among all adults as described in the previous section, as well as widespread uptake of option B+ and emerging programme data

High incidence and prevalence of sexually transmitted infections (STIs) in HIV pre-exposure prophylaxis (PrEP) users: systematic review and analysis.. (Manuscript

Following the WHO recommendation in September 2015 that “oral pre-exposure prophylaxis (PrEP) should be offered as an additional prevention choice for people at substantial risk of

All people at substantial risk of HIV infection who could be eligible for PrEP should be offered HIV testing services. Prior to starting or restarting PrEP, it is critical to rule